/4571.T
4571.T Stock - NANO MRNA Co.,Ltd.
Healthcare|BiotechnologyJPX
$146.00-1.35%
$2.00 (-1.35%) • Jan 16
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.51
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $160.60
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for 4571.T
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$144.54 – $147.46
TARGET (TP)$167.90
STOP LOSS$134.32
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.16
52W High$254.00
52W Low$113.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $108.52M | $135.51M | $202.19M | $264.03M | $313.26M |
| Gross Profit | $78.17M | $110.96M | $159.60M | $222.74M | $274.89M |
| Gross Margin | 72.0% | 81.9% | 78.9% | 84.4% | 87.8% |
| Operating Income | $-755,349,000 | $-864,415,000 | $-1,246,000,000 | $-2,061,088,000 | $-1,302,882,000 |
| Net Income | $-835,380,000 | $-780,002,000 | $-1,310,976,000 | $-1,881,678,000 | $-2,835,793,000 |
| Net Margin | -769.8% | -575.6% | -648.4% | -712.7% | -905.2% |
| EPS | $-11.85 | $-11.10 | $-18.70 | $-26.90 | $-41.53 |
Company Overview
NANO MRNA Co., Ltd. engages in the research, development, and production of pharmaceuticals using micellar nanoparticles technology. The company develops biopharmaceutical products focused on the medication of cancer and other intractable diseases. It also engages in the research, development, manufacture, and sale of anti-cancer drugs based on micellar nanoparticle technology. The company was founded by Kazunori Kataoka, Teruo Okano, and Ichiro Nakatomi on June 14, 1996 and is headquartered in Tokyo, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
4571.TBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-3.36
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 14, 2025 | — | $-3.36 | — | — |
Q3 2025 | Aug 8, 2025 | — | $-2.85 | — | — |
Q2 2025 | May 14, 2025 | — | $-3.40 | — | — |
Q1 2025 | Feb 12, 2025 | — | $-1.09 | — | — |
Q4 2024 | Nov 14, 2024 | — | $-5.14 | — | — |
Q3 2024 | Aug 9, 2024 | — | $-2.22 | — | — |
Q2 2024 | May 14, 2024 | — | $-0.60 | — | — |
Q1 2024 | Feb 14, 2024 | — | $-3.69 | — | — |
Q4 2023 | Nov 10, 2023 | — | $-2.73 | — | — |
Q3 2023 | Aug 10, 2023 | — | $-4.07 | — | — |
Q2 2023 | May 12, 2023 | — | $-4.44 | — | — |
Q1 2023 | Feb 14, 2023 | — | $-1.60 | — | — |
Q4 2022 | Nov 11, 2022 | — | $-7.97 | — | — |
Q3 2022 | Aug 10, 2022 | — | $-4.68 | — | — |
Q2 2022 | May 12, 2022 | — | $-6.70 | — | — |
Q1 2022 | Feb 10, 2022 | — | $-6.25 | — | — |
Q4 2021 | Nov 12, 2021 | — | $-7.29 | — | — |
Q3 2021 | Aug 13, 2021 | — | $-6.65 | — | — |
Q2 2021 | May 13, 2021 | — | $-5.51 | — | — |
Q1 2021 | Feb 10, 2021 | — | $-5.27 | — | — |
Latest News
Loading news...
Frequently Asked Questions about 4571.T
What is 4571.T's current stock price?
NANO MRNA Co.,Ltd. (4571.T) is currently trading at $146.00 per share. The stock has moved -1.35% today.
What is the analyst price target for 4571.T?
No analyst price targets are currently available for this stock.
What sector is NANO MRNA Co.,Ltd. in?
NANO MRNA Co.,Ltd. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the JPX exchange.
What is 4571.T's market cap?
NANO MRNA Co.,Ltd. has a market capitalization of $10.33 billion, making it a large-cap company.
Does 4571.T pay dividends?
No, NANO MRNA Co.,Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare Sector2183.T
Linical Co., Ltd.
$320.00
Mkt Cap: $7.2B
2370.T
MEDINET Co., Ltd.
$31.00
Mkt Cap: $8.2B
3544.T
Satudora Holdings Co.,Ltd.
$831.00
Mkt Cap: $11.5B
4579.T
RaQualia Pharma Inc.
$1062.00
Mkt Cap: $26.0B
4583.T
Chiome Bioscience Inc.
$119.00
Mkt Cap: $8.1B
4584.T
Kidswell Bio Corporation
$260.00
Mkt Cap: $12.9B
4875.T
MediciNova, Inc.
$259.00
Mkt Cap: $12.7B
4880.T
CellSource Co., Ltd.
$429.00
Mkt Cap: $8.5B
4888.T
Stella Pharma Corporation
$237.00
Mkt Cap: $8.1B
7776.T
CellSeed Inc.
$341.00
Mkt Cap: $11.8B
Explore stocks similar to 4571.T for comparison